PRESS RELEASE published on 05/15/2025 at 14:31, 8 months 16 days ago Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2025 and the appointment of a new Supervisory Board. Key decisions made include new board members and Dr. Karl Benedikt Biesinger elected as Chairman Annual General Meeting Supervisory Board Heidelberg Pharma AG ADCs Dr. Karl Benedikt Biesinger
BRIEF published on 05/14/2025 at 18:45, 8 months 17 days ago Heidelberg Pharma dévoilera les données cliniques du HDP-101 à l'EHA 2025 Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple EHA 2025
BRIEF published on 05/14/2025 at 18:45, 8 months 17 days ago Heidelberg Pharma to Unveil Clinical Data on HDP-101 at EHA 2025 Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma EHA 2025
PRESS RELEASE published on 05/14/2025 at 18:40, 8 months 17 days ago Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 Heidelberg Pharma to present new clinical data on lead ATAC candidate HDP-101 at EHA 2025. Promising results in Multiple Myeloma treatment. R&D webinar to follow Clinical Data Heidelberg Pharma Multiple Myeloma ATAC Candidate EHA 2025
BRIEF published on 04/24/2025 at 07:21, 9 months 7 days ago Heidelberg Pharma AG's First Quarter Financial Report for 2025 Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs
BRIEF published on 04/24/2025 at 07:21, 9 months 7 days ago Rapport financier du premier trimestre 2025 de Heidelberg Pharma AG Essais Cliniques Heidelberg Pharma Perspectives 2025 État Financier Programmes ADC
PRESS RELEASE published on 04/24/2025 at 07:16, 9 months 7 days ago Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF published on 03/26/2025 at 09:28, 10 months 5 days ago Heidelberg Pharma to Showcase ADC Innovations at AACR 2025 Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
BRIEF published on 03/26/2025 at 09:28, 10 months 5 days ago Heidelberg Pharma présentera ses innovations ADC à l'AACR 2025 Heidelberg Pharma HDP-201 Technologie ADC AACR 2025 Inhibiteurs De NAMPT
PRESS RELEASE published on 03/26/2025 at 09:23, 10 months 5 days ago Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC
Published on 01/31/2026 at 03:15, 1 day 5 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 6 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 9 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 16 hours 28 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 19 hours 57 minutes ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 5 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 10 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 12 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 13 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 14 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 14 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 23 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés